adenosine diphosphate has been researched along with iloprost in 52 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 22 (42.31) | 18.7374 |
1990's | 21 (40.38) | 18.2507 |
2000's | 3 (5.77) | 29.6817 |
2010's | 5 (9.62) | 24.3611 |
2020's | 1 (1.92) | 2.80 |
Authors | Studies |
---|---|
Ashby, B; Dangelmaier, C; Daniel, J; Selak, MA; Smith, JB | 1 |
Buerke, M; Darius, H; Dieterich, HA; Meyer, J | 1 |
Keen, M; Kelly, E; MacDermot, J; Nobbs, P | 1 |
Mollace, V; Moore, A; Radziszewski, W; Salvemini, D; Vane, J; Willoughby, D | 1 |
Buzzi, E; Colao, C; Leoncini, G; Maresca, M; Mazzei, M | 1 |
Galli, C; Grassi, G; Lograno, MD; Marangoni, F; Medini, L; Mosconi, C | 1 |
Abi-Younes, SA; Ayers, ML; Myers, AK | 1 |
Bull, H; Machin, SJ; Mackie, IJ; Yardumian, DA | 1 |
Colli, S; Maderna, P; Paoletti, R; Sirtori, C; Tremoli, E | 1 |
Kutti, J; Wadenvik, H | 1 |
Skuballa, W; Vorbrüggen, H | 2 |
Brennan, EC; Bull, H; Machin, SJ; Mackie, IJ; Yardumian, DA | 1 |
Addonizio, VP; Cottrell, ED; Fisher, CA; Kappa, JR; Reiser, HJ; Sinha, AK | 1 |
Addonizio, VP; Fisher, CA; Kappa, JR; Musial, J | 1 |
Linch, DC; Machin, SJ; O'Flynn, K; Yardumian, DA | 1 |
Barbenel, JC; Belch, JJ; Forbes, CD; Lowe, GD; Saniabadi, AR | 1 |
Clarke, BF; Collier, A; Jones, RL; Matthews, DM; Tymkewycz, PM | 1 |
Fitscha, P; Sinzinger, H; Tiso, B | 1 |
Cohen, H; Machin, SJ; Mackie, IJ; Neild, GH; Patel, R | 1 |
Faul, C; Jaschonek, K; Renn, W; Schmidt, H | 1 |
Frojmovic, MM; Pedvis, LG; Wong, T | 1 |
Stürzebecher, S; Witt, W | 1 |
Lapetina, EG; Molina y Vedia, L; Nolan, RD | 1 |
Macagni, A; Pozza, G; Vicari, AM | 1 |
Maass, B; Müller, B; Skuballa, W; Stürzebecher, S | 1 |
Barbenel, JC; Belch, JJ; Forbes, CD; Lowe, GD; Prentice, CR; Saniabadi, AR | 1 |
Adaikan, PG; Karim, SM; Kottegoda, SR; Lau, LC; Tai, MY | 1 |
Jones, R; Machin, SJ; Mackie, IJ | 1 |
Brassard, CL; Buchanan, JO; Gougoutas, JZ; Malley, MF; Martin, SW; Meanwell, NA; Romine, JL; Rosenfeld, MJ; Trehan, AK; Wright, JJ | 1 |
Anfossi, G; Cavalot, F; Massucco, P; Mattiello, L; Mularoni, E; Trovati, M | 1 |
Braun, M; Hohlfeld, T; Scharnowski, F; Schrör, K | 1 |
Bernabei, A; Edmunds, LH; Gikakis, N; Kowalska, MA; Niewiarowski, S | 1 |
Andrews, R; Heptinstall, S; May, JA; Vickers, J | 1 |
Armstrong, R; Heptinstall, S; Lösche, W; May, JA | 1 |
Hohlfeld, T; Schrör, K; Strobach, H; Weber, AA | 1 |
Abiko, Y; Ichihara, K; Yamamoto, K | 1 |
Grünberg, B; Siess, W | 1 |
Cohen, H; Enayat, ZE; Flores, NA; Goulielmos, NV; Sheridan, DJ | 1 |
Chinellato, A; Doni, MG; Meggiato, C; Padoin, E; Ragazzi, E | 1 |
Ayaz, S; Katircioğlu, SF; Saritaş, Z; Ulus, AT; Yamak, B; Yücel, D | 1 |
Glenn, JR; Heptinstall, S | 1 |
Doni, MG; Picunio, S; Simioni, M | 1 |
Akkerman, JW; den Dekker, E; Gorter, G; Heemskerk, JW; van der Vuurst, H | 1 |
Kobzar, G; Mardla, V; Samel, N | 1 |
Buerkle, MA; Conzen, P; Krötz, F; Lehrer, S; Pohl, U; Sohn, HY | 1 |
Anfossi, G; Bonomo, K; Cavalot, F; De Salve, A; Del Mese, P; Doronzo, G; Mattiello, L; Russo, I; Traversa, M; Trovati, M | 1 |
Brunner, KP; Kobsar, AL; Koessler, J; Rajkovic, MS; Steigerwald, U; Walter, U | 1 |
Beck, F; Buhs, S; Geiger, J; Gerull, H; Nollau, P; Schweigel, H; Sickmann, A; Walter, U | 1 |
Dhillon, K; Dovlatova, N; Fox, SC; Glenn, JR; Heptinstall, S; White, AE | 1 |
Beck, F; Burkhart, JM; Dell'Aica, M; Fufezan, C; Gambaryan, S; Geiger, J; Heemskerk, JW; Jurk, K; Loroch, S; Mattheij, NJ; Mindukshev, I; Pötz, O; Sickmann, A; Solari, FA; Walter, U; Zahedi, RP | 1 |
Costa, JL; Leonardi, GR; Lescano, CH; Mazetto, B; Monica, FZ; Orsi, FA | 1 |
3 trial(s) available for adenosine diphosphate and iloprost
Article | Year |
---|---|
Iloprost in peripheral vascular disease--platelet function and clinical outcome.
Topics: Adenosine Diphosphate; Blood Platelets; Cardiovascular Agents; Clinical Trials as Topic; Collagen; Epoprostenol; Humans; Iloprost; Male; Pain; Platelet Aggregation; Random Allocation; Vascular Diseases | 1987 |
Inhibition of platelet aggregation by transdermal glyceryl trinitrate.
Topics: Adenosine Diphosphate; Administration, Cutaneous; Cross-Over Studies; Humans; Iloprost; Nitric Oxide; Nitroglycerin; Platelet Aggregation; Platelet Function Tests; Prospective Studies | 1994 |
In central obesity, weight loss restores platelet sensitivity to nitric oxide and prostacyclin.
Topics: Adenosine Diphosphate; Adipose Tissue; Adult; Blood Platelets; Cyclic AMP; Cyclic GMP; Diet, Reducing; Endothelium, Vascular; Epoprostenol; Female; Humans; Iloprost; Insulin Resistance; Male; Nitric Oxide; Nitroprusside; Obesity, Abdominal; Platelet Activation; Platelet Aggregation Inhibitors; Weight Loss | 2010 |
49 other study(ies) available for adenosine diphosphate and iloprost
Article | Year |
---|---|
Cyclic AMP does not inhibit collagen-induced platelet signal transduction.
Topics: Adenosine Diphosphate; Blood Platelets; Calcium; Collagen; Cyclic AMP; Fluorescent Dyes; Fura-2; Humans; Iloprost; Platelet Adhesiveness; Prostaglandin D2; Prostaglandin Endoperoxides, Synthetic; Serotonin; Signal Transduction; Thrombin | 1992 |
Synergistic platelet inhibitory effect of the phosphodiesterase inhibitor piroximone and iloprost.
Topics: Adenosine Diphosphate; Adenylyl Cyclases; Animals; Collagen; Cyclic AMP; Drug Synergism; Enzyme Activation; Humans; Iloprost; Imidazoles; In Vitro Techniques; Male; Phosphodiesterase Inhibitors; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Count; Rats; Rats, Inbred Strains | 1992 |
Segregation of discrete GS alpha-mediated responses that accompany homologous or heterologous desensitization in two related somatic hybrids.
Topics: Adenosine; Adenosine Diphosphate; Adenosine-5'-(N-ethylcarboxamide); Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Animals; Cell Line; Epoprostenol; GTP-Binding Proteins; Hybrid Cells; Iloprost; Kinetics; Mice; Morphine; Neuroblastoma; Phosphorus Radioisotopes; Receptors, Epoprostenol; Receptors, Prostaglandin; Sodium Fluoride | 1990 |
Diphenylene iodonium, an inhibitor of free radical formation, inhibits platelet aggregation.
Topics: Adenosine Diphosphate; Biphenyl Compounds; Cyclic AMP; Cyclic GMP; Endothelium, Vascular; Free Radicals; Humans; Iloprost; In Vitro Techniques; Leukocytes; NADH, NADPH Oxidoreductases; Nitroprusside; Onium Compounds; Platelet Aggregation; Platelet Aggregation Inhibitors; Thrombin | 1991 |
Mode of action of 2-(diethylamino)-7-ethoxychromone on human platelets.
Topics: Adenosine Diphosphate; Adenylyl Cyclases; Chromones; Colforsin; Collagen; Cyclic AMP; Humans; Iloprost; Phosphoric Diester Hydrolases; Platelet Aggregation; Platelet Aggregation Inhibitors; Prostaglandin Endoperoxides, Synthetic; Thrombin; Thromboxane A2 | 1991 |
Vascular eicosanoids and platelet-aortic wall interactions in spontaneously hypertensive rats.
Topics: 6-Ketoprostaglandin F1 alpha; Adenosine Diphosphate; Animals; Aorta; Blood Platelets; Collagen; Hypertension; Iloprost; Male; Perfusion; Platelet Aggregation; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Thromboxane B2 | 1991 |
Mechanism of ethanol-induced aggregation in whole blood.
Topics: Adenosine Diphosphate; Animals; Apyrase; Collagen; Ethanol; Female; Hemolysis; Humans; Iloprost; In Vitro Techniques; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Rats; Rats, Inbred Strains | 1991 |
Platelet responses observed during and after infusions of the prostacyclin analog ZK 36 374.
Topics: Adenosine Diphosphate; Arterial Occlusive Diseases; Blood Platelets; Cardiovascular Agents; Collagen; Epoprostenol; Fingers; Humans; Iloprost; Ischemia; Male; Middle Aged; Platelet Aggregation; Scleroderma, Systemic; Time Factors | 1985 |
Control of human and animal platelet aggregation by a new prostacyclin analog.
Topics: Adenosine Diphosphate; Animals; Cardiovascular Agents; Collagen; Dose-Response Relationship, Drug; Epinephrine; Epoprostenol; Humans; Iloprost; Male; Platelet Aggregation; Rabbits; Rats | 1985 |
Effect of Iloprost (ZK 36 374), a novel prostacyclin analogue, on ADP-induced platelet aggregation.
Topics: Adenosine Diphosphate; Adult; Dose-Response Relationship, Drug; Epoprostenol; Humans; Iloprost; Male; Platelet Aggregation | 1985 |
Synthesis of ZK-96,480: a chemically and metabolically stable potent prostacyclin analogue.
Topics: Adenosine Diphosphate; Epoprostenol; Humans; Iloprost; Indicators and Reagents; Platelet Aggregation | 1985 |
Platelet function studies during and after infusions of ZK 36374, a stable prostacyclin analogue, to healthy volunteers.
Topics: Adenosine Diphosphate; Adult; Collagen; Epoprostenol; Humans; Iloprost; In Vitro Techniques; Male; Middle Aged; Platelet Aggregation; Thromboxane B2; Time Factors | 1986 |
Comparison of equimolar concentrations of iloprost, prostacyclin, and prostaglandin E1 on human platelet function.
Topics: Adenosine Diphosphate; Alprostadil; Animals; Coronary Circulation; Cyclic AMP; Epinephrine; Epoprostenol; Humans; Iloprost; In Vitro Techniques; Platelet Aggregation; Rats; Thrombin | 1987 |
Quantitation of platelet preservation with prostanoids during simulated bypass.
Topics: Adenosine Diphosphate; Alprostadil; Blood Platelets; Blood Specimen Collection; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Epinephrine; Epoprostenol; Extracorporeal Circulation; Humans; Iloprost; Platelet Count; Prostaglandins | 1987 |
Interactions between prostacyclin analogue ZK 36374 and heparin in their effects upon platelet function.
Topics: Adenosine Diphosphate; Blood Platelets; Calcium; Dose-Response Relationship, Drug; Drug Interactions; Epoprostenol; Heparin; Humans; Iloprost; Platelet Aggregation; Thrombin | 1987 |
Comparison of inhibitory actions of prostacyclin and a new prostacyclin analogue on the aggregation of human platelet in whole blood.
Topics: Adenosine Diphosphate; Arachidonic Acid; Arachidonic Acids; Blood Physiological Phenomena; Dose-Response Relationship, Drug; Epinephrine; Epoprostenol; Erythrocytes; Humans; Iloprost; Methods; Platelet Aggregation | 1987 |
Changes in some aspects of platelet function with improvement of glycaemic control over 6 months.
Topics: Adenosine Diphosphate; Adult; Blood Glucose; Blood Platelets; Cyclic AMP; Diabetes Mellitus, Type 1; Epoprostenol; Humans; Iloprost; Male; Platelet Aggregation; Thromboxane B2; Time Factors | 1987 |
Evidence for chronic platelet hyperaggregability and in vivo activation in cyclosporin-treated renal allograft recipients.
Topics: Adenine Nucleotides; Adenosine Diphosphate; Adult; Blood Platelets; Cyclosporins; Epoprostenol; Female; Humans; Iloprost; In Vitro Techniques; Kidney Transplantation; Male; Middle Aged; Platelet Aggregation; Thrombosis; Time Factors | 1988 |
Desensitization of platelets to iloprost. Loss of specific binding sites and heterologous desensitization of adenylate cyclase.
Topics: Adenosine Diphosphate; Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Blood Platelets; Cardiovascular Agents; Colforsin; Cyclic AMP; Electrophoresis, Polyacrylamide Gel; Epoprostenol; Humans; Iloprost; In Vitro Techniques; Kinetics; Phosphorus Radioisotopes; Ribose | 1988 |
Differential inhibition of the platelet activation sequence: shape change, micro- and macro-aggregation, by a stable prostacyclin analogue (Iloprost).
Topics: Adenosine Diphosphate; Adult; Blood Platelets; Dose-Response Relationship, Drug; Epoprostenol; Female; Humans; Iloprost; In Vitro Techniques; Male; Middle Aged; Platelet Aggregation | 1988 |
The PGI2-analogue iloprost and the TXA2-receptor antagonist sulotroban synergistically inhibit TXA2-dependent platelet activation.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Diphosphate; Aspirin; Bridged Bicyclo Compounds, Heterocyclic; Collagen; Drug Synergism; Epoprostenol; Fatty Acids, Unsaturated; Humans; Hydrazines; Iloprost; In Vitro Techniques; Platelet Aggregation; Platelet Aggregation Inhibitors; Prostaglandin Endoperoxides, Synthetic; Prostaglandins, Synthetic; Receptors, Prostaglandin; Receptors, Thromboxane; Sulfonamides | 1988 |
The effect of iloprost on the ADP-ribosylation of Gs alpha (the alpha-subunit of Gs).
Topics: Adenosine Diphosphate; Blood Platelets; Cell Membrane; Cell Membrane Permeability; Cholera Toxin; Epoprostenol; GTP-Binding Proteins; Humans; Iloprost; Poly(ADP-ribose) Polymerases | 1989 |
Platelet sensitivity in vitro to the prostacyclin analogue iloprost in diabetic patients.
Topics: Adenosine Diphosphate; Adult; Collagen; Diabetes Mellitus, Type 1; Epoprostenol; Female; Humans; Iloprost; In Vitro Techniques; Male; Platelet Aggregation; Platelet Aggregation Inhibitors | 1989 |
Antifibrillatory action of the stable orally active prostacyclin analogues iloprost and ZK 96 480 in rats after coronary artery ligation.
Topics: Adenosine Diphosphate; Animals; Arrhythmias, Cardiac; Blood Pressure; Cardiovascular Agents; Epoprostenol; Iloprost; Lidocaine; Platelet Aggregation; Rats; Rats, Inbred SHR; Reserpine | 1984 |
Synthesis of ciloprost (ZK 36 374): a chemically stable and biologically potent prostacyclin analog.
Topics: Adenosine Diphosphate; Cardiovascular Agents; Epoprostenol; Humans; Iloprost; Indicators and Reagents; Molecular Conformation; Platelet Aggregation; Prostaglandins; Structure-Activity Relationship | 1983 |
The novel effect of a new prostacyclin analogue ZK36374 on the aggregation of human platelets in whole blood.
Topics: Adenosine Diphosphate; Cardiovascular Agents; Collagen; Epoprostenol; Humans; Iloprost; Platelet Aggregation; Platelet Count; Thrombin | 1983 |
Inhibition of platelet aggregation and antagonism of vasopressin-induced ECG changes in primates by a carboprostacyclin analogue, ZK 36374.
Topics: Adenosine Diphosphate; Animals; Blood Pressure; Dose-Response Relationship, Drug; Electrocardiography; Epoprostenol; Humans; Iloprost; Papio; Platelet Aggregation; Vasopressins | 1984 |
Platelet impedance aggregation in whole blood and its inhibition by antiplatelet drugs.
Topics: Adenosine Diphosphate; Adult; Arachidonic Acid; Arachidonic Acids; Collagen; Electrodes; Epoprostenol; Hematocrit; Humans; Iloprost; Platelet Aggregation; Platelet Count; Plethysmography, Impedance | 1984 |
Nonprostanoid prostacyclin mimetics. 5. Structure-activity relationships associated with [3-[4-(4,5-diphenyl-2-oxazolyl)-5- oxazolyl]phenoxy]acetic acid.
Topics: Acetates; Adenosine Diphosphate; Binding, Competitive; Crystallization; Epoprostenol; Humans; Hydrogen Bonding; Iloprost; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Conformation; Molecular Structure; Oxazoles; Platelet Aggregation; Platelet Aggregation Inhibitors; Receptors, Epoprostenol; Receptors, Prostaglandin; Structure-Activity Relationship | 1993 |
Organic nitrates and compounds that increase intraplatelet cyclic guanosine monophosphate (cGMP) levels enhance the antiaggregating effects of the stable prostacyclin analogue iloprost.
Topics: 1-Methyl-3-isobutylxanthine; Adenosine Diphosphate; Adult; Arginine; Blood Platelets; Collagen; Cyclic AMP; Cyclic GMP; Drug Synergism; Endothelium, Vascular; Epinephrine; Humans; Iloprost; Intracellular Fluid; Male; Nitroglycerin; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Factor 4; Second Messenger Systems | 1993 |
Antiplatelet effects of ticlopidine are reduced in experimental hypercholesterolemia.
Topics: Adenosine Diphosphate; Animals; Aortic Diseases; Arteriosclerosis; Biotransformation; Cholesterol, Dietary; Collagen; Cyclic AMP; Hypercholesterolemia; Iloprost; Indomethacin; Liver; Male; Platelet Aggregation; Rabbits; Signal Transduction; Thromboxane B2; Ticlopidine | 1994 |
Iloprost and echistatin protect platelets during simulated extracorporeal circulation.
Topics: Adenosine Diphosphate; beta-Thromboglobulin; Blood Platelets; Cardiopulmonary Bypass; Colforsin; Cyclic AMP; Epinephrine; Humans; Iloprost; In Vitro Techniques; Intercellular Signaling Peptides and Proteins; Oligopeptides; Peptides; Platelet Adhesiveness; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Viper Venoms | 1995 |
Factors that contribute to spontaneous platelet aggregation and streptokinase-induced aggregation in whole blood.
Topics: Adenosine Diphosphate; Amino Acid Sequence; Hirudins; Humans; Iloprost; Magnesium Chloride; Molecular Sequence Data; Molsidomine; Platelet Aggregation; Platelet Aggregation Inhibitors; Reference Values; Streptokinase; Thromboxane A2 | 1995 |
Oral naftidrofuryl prevents platelet hyperreactivity ex vivo and inhibits functional desensitization to prostacyclin in hypercholesterolemic rabbits.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Blood Platelets; Cholesterol; Collagen; Diet; Epoprostenol; Humans; Hypercholesterolemia; Iloprost; In Vitro Techniques; Male; Nafronyl; Platelet Aggregation; Platelet Aggregation Inhibitors; Rabbits; Thromboxanes | 1993 |
Effects of iloprost, a PGI2 derivative, on ischemic myocardial energy and carbohydrate metabolism in dogs.
Topics: Adenosine Diphosphate; Animals; Dogs; Energy Metabolism; Female; Fructosediphosphates; Glucose-6-Phosphate; Glucosephosphates; Glycogen; Heart; Hemodynamics; Iloprost; Lactates; Male; Myocardial Ischemia; Phosphocreatine | 1993 |
Phosphorylation of rap1B by protein kinase A is not involved in platelet inhibition by cyclic AMP.
Topics: Adenosine Diphosphate; Collagen; Cyclic AMP; Epinephrine; GTP-Binding Proteins; Humans; Iloprost; Phorbol Esters; Phosphorylation; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Protein Kinases; rab1 GTP-Binding Proteins; Signal Transduction; Vasopressins | 1993 |
Nitric oxide and prostacyclin modulate the alterations in cardiac action potential duration mediated by platelets during ischaemia.
Topics: Action Potentials; Adenosine Diphosphate; Animals; Arginine; Blood Platelets; Collagen; Epoprostenol; Guinea Pigs; Heart; Hemoglobins; Iloprost; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitroprusside; Perfusion; Platelet Aggregation Inhibitors; Vasodilator Agents | 1995 |
Inhibition of platelet activation by MM-706, a stable carbacyclin analog, in the conscious rat.
Topics: Adenosine Diphosphate; Animals; Blood Pressure; Epoprostenol; Heart Rate; Iloprost; Male; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Count; Rats; Rats, Wistar | 1997 |
Iloprost added to the cardioplegic solutions improves myocardial performance.
Topics: Adenosine Diphosphate; Animals; Cardioplegic Solutions; Dogs; Hemodynamics; Iloprost; Myocardial Contraction; Myocardium; P-Selectin; Platelet Aggregation Inhibitors; Tumor Necrosis Factor-alpha; Vasodilator Agents | 1998 |
Evidence that adenosine diphosphate can activate adenylate cyclase via conversion to adenosine in platelet-rich plasma containing magnesium.
Topics: Adenosine; Adenosine Diphosphate; Adenosine Triphosphate; Adenylyl Cyclases; Colforsin; Cyclic AMP; Enzyme Activation; Humans; Iloprost; Magnesium; Platelet Aggregation Inhibitors; Platelet Count; Quinazolines; Receptors, Purinergic P2; Reference Values | 1998 |
Platelet activation and modulation of the induction of nitric oxide synthase in the conscious rat.
Topics: Adenosine Diphosphate; Animals; Blood Pressure; Enzyme Induction; Heart Rate; Iloprost; Lipopolysaccharides; Male; Nitrates; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrites; Penicillamine; Platelet Activation; Platelet Count; Rats; Rats, Wistar; Thrombocytopenia | 1999 |
Biogenesis of G-protein mediated calcium signaling in human megakaryocytes.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Diphosphate; Animals; Blood Platelets; Calcium; Calcium Signaling; Cattle; Cell Differentiation; Cells, Cultured; Fetal Blood; Flow Cytometry; Gene Expression Regulation, Developmental; GTP-Binding Protein alpha Subunit, Gi2; GTP-Binding Protein alpha Subunits, Gi-Go; GTP-Binding Protein alpha Subunits, Gq-G11; GTP-Binding Protein alpha Subunits, Gs; Heterotrimeric GTP-Binding Proteins; Humans; Iloprost; Megakaryocytes; Platelet Activating Factor; Protein Isoforms; Proto-Oncogene Proteins; Stem Cells; Thrombin; Thrombopoietin | 2001 |
Potentiation of antiaggregating effect of prostaglandins by alpha-tocopherol and quercetin.
Topics: Adenosine Diphosphate; Adult; alpha-Tocopherol; Alprostadil; Blood Platelets; Dose-Response Relationship, Drug; Drug Synergism; Epoprostenol; Female; Humans; Iloprost; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Prostaglandins; Quercetin | 2004 |
Selective inhibition of cyclooxygenase-2 enhances platelet adhesion in hamster arterioles in vivo.
Topics: 6-Ketoprostaglandin F1 alpha; Adenosine Diphosphate; Animals; Arterioles; Aspirin; Cells, Cultured; Cricetinae; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Endothelial Cells; Endothelium, Vascular; Humans; Iloprost; Membrane Proteins; Mesocricetus; Nitrobenzenes; Platelet Activation; Platelet Adhesiveness; Platelet Aggregation Inhibitors; Prostaglandin-Endoperoxide Synthases; Skin Window Technique; Sulfonamides; Thrombophilia; Umbilical Veins | 2004 |
Prostacyclin receptor stimulation facilitates detection of human platelet P2Y(12) receptor inhibition by the PFA-100 system.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adult; Blood Platelets; Cell Adhesion Molecules; Clopidogrel; Female; Flow Cytometry; Humans; Iloprost; Male; Microfilament Proteins; Middle Aged; Phosphoproteins; Phosphorylation; Platelet Aggregation Inhibitors; Purinergic P2 Receptor Antagonists; Receptors, Epoprostenol; Receptors, Purinergic P2Y12; Ticlopidine; Young Adult | 2010 |
Deciphering of ADP-induced, phosphotyrosine-dependent signaling networks in human platelets by Src-homology 2 region (SH2)-profiling.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Blood Platelets; Cyclic AMP-Dependent Protein Kinases; Enzyme Activation; Humans; Iloprost; Phosphorylation; Phosphotyrosine; Platelet Activation; Protein Processing, Post-Translational; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y1; Receptors, Purinergic P2Y12; Signal Transduction; src Homology Domains; Tandem Mass Spectrometry | 2013 |
'VASPFix' for measurement of VASP phosphorylation in platelets and for monitoring effects of P2Y12 antagonists.
Topics: Adenosine; Adenosine Diphosphate; Alprostadil; Biomarkers, Pharmacological; Blood Platelets; Bucladesine; Cell Adhesion Molecules; Cells, Cultured; Clopidogrel; Cyclic AMP; Humans; Iloprost; Microfilament Proteins; Phosphoproteins; Phosphorylation; Piperazines; Platelet Aggregation; Platelet Function Tests; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Reproducibility of Results; Sensitivity and Specificity; Thiophenes; Thrombophilia; Ticlopidine | 2014 |
Temporal quantitative phosphoproteomics of ADP stimulation reveals novel central nodes in platelet activation and inhibition.
Topics: Adenosine Diphosphate; Blood Platelets; Blotting, Western; Humans; Iloprost; Phosphorylation; Platelet Activation; Platelet Aggregation Inhibitors; Proteomics; Signal Transduction | 2017 |
Adenosine diphosphate-induced aggregation is enhanced in platelets obtained from patients with thrombotic primary antiphospholipid syndrome (t-PAPS): Role of P2Y
Topics: Adenosine Diphosphate; Antiphospholipid Syndrome; Blood Platelets; Cyclic AMP; Cyclic GMP; Humans; Iloprost; Nitroprusside; Platelet Aggregation; Platelet Aggregation Inhibitors; Signal Transduction | 2022 |